Stock overview
Akebia Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
AKEBIA THERAPEUTICS INC (AKBA) is a healthcare or biotechnology equity security tracked from 13F filings.
AKBA · USD
Price
$0.92
+$0.04
(+5.15%)
over selected range
Close · Sep 16, 2026
Market closed
23 stored daily closes
$0.92
Sep 16, 2026
- Range low
- $0.85
- Range high
- $1.03
- Observations
- 23
- Session date
- Sep 16, 2026
Aug 14, 2026–Sep 16, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | −33% 26'Q2 | $1,395,318 | 0% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +33% 26'Q2 | $41,100 | 0% |
SEC Forms 4/5
Insiders
SEC fundamentals
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market